Testing two Zika vaccines for positive results

US researchers on September 22 announced that two Zika vaccines prepared by the US National Institutes of Health (NIH) have shown positive results when tested on short-tailed macaque.

NIH confirmed that after receiving two doses of VRC5288 and VRC5283 in different doses, the experimental monkeys were able to produce Zika anti-virus effectively.

Meanwhile, a study published in Science magazine published on the same day said that VRC5288 vaccine has begun to be tested clinically on humans. If determined effectively and safely, VRC5288 can begin to be tested in countries with Zika virus outbreak next year.

Vaccination VRC5288 has begun to be conducted on human clinical trials.

Meanwhile, the vaccine VRC5283 is still waiting to be tested in phase 1. Health experts think it takes a lot of testing time before ensuring a vaccine against Zika virus. can be marketed.

Zika virus spreads to people mainly when being burned by Aedes aegypti and can also be spread through sex. People infected with Zika have milder symptoms with dengue fever or typhus - most common when infected are fever, conjunctivitis, headache, muscle and joint pain, rash.

This virus is particularly dangerous for pregnant women because if the mother is infected, the baby is born with a small head malformation or other health problems.

Zika virus has now appeared in more than 50 countries around the world and broke out in Latin America. Brazil is the most severely affected country in this Zika virus outbreak, with about 1.5 million patients.